%0 Journal Article
%T EBV重激活的研究进展<br>Research Progress on EBV Reactivation
%A 李由
%A 李用国
%J Advances in Clinical Medicine
%P 467-473
%@ 2161-8720
%D 2024
%I Hans Publishing
%R 10.12677/ACM.2024.143725
%X EB病毒(Epstein-Barr Virus, EBV)是一种在人群中广泛存在的病毒，它在人类生命周期中的某个时刻几乎无一例外地会感染到每个人。EBV通常能在人体B细胞和上皮细胞中建立长期潜伏感染，且在特定条件下可能重新激活。EBV的重激活与多种肿瘤性疾病相关，包括淋巴瘤和胃肠癌等。虽然目前没有官方批准的治疗方法，但已有研究显示某些抗病毒药物和质子泵抑制剂能有效抑制EBV的复制。但对于潜伏感染的治疗效果有限，因此需要更多研究来开发新的治疗策略。<br />
Epstein-Barr Virus (EBV) is a virus that is widely prevalent in the human population, infecting nearly everyone at some point during their lifetime. EBV typically establishes long-term latent in-fections in human B cells and epithelial cells, and can reactivate under certain conditions. Reacti-vation of EBV is associated with various tumorigenic diseases, including lymphomas and gastro-intestinal cancers. Although there are no officially approved treatments to date, studies have shown that certain antiviral drugs and proton pump inhibitors can effectively inhibit EBV replication. However, their effectiveness on latent infections is limited, necessitating further research to develop new therapeutic strategies.
%K EBV，潜伏期，重新激活，免疫，治疗<br>EBV
%K Latency
%K Reactivation
%K Immunity
%K Treatment
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=82667